Muscle channelopathies and related diseases

Handbook of Clinical Neurology

Volumn 113, Issue , 2013, Pages 1433-1436

  Fontaine, Bertrand ^a  

^a INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876819853     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-59565-2.00012-5     Document Type: Chapter

References (14)

1. Fontaine B., Fournier E., Sternberg D., et al. Hypokalemic periodic paralysis: a model for a clinical and research approach to a rare disorder. Neurotherapeutics 2007, 4:225-232.
2. Fournier E., Arzel M., Sternberg D., et al. Electromyography guides toward subgroups of mutations in muscle channelopathies. Ann Neurol 2004, 56:650-661.
3. Fournier E., Viala K., Gervais H., et al. Cold extends electromyography distinction between ion channel mutations causing myotonia. Ann Neurol 2006, 60:356-365.
4. Gay S., Dupuis D., Faivre L., et al. Severe neonatal non-dystrophic myotonia secondary to a novel mutation of the voltage-gated sodium channel (SCN4A) gene. Am J Med Genet A 2008, 146:380-383.
5. Jentsch T.J., Poet M., Fuhrmann J.C., et al. Physiological functions of CLC Cl-channels gleaned from human genetic disease and mouse models. Annu Rev Physiol 2005, 67:779-807.
6. Lion-François L., Mignot C., Vicart S., et al. Severe neonatal episodic laryngospasm due to de novo SCN4A mutations: a new treatable disorder. Neurology 2010, 75:641-645.
7. Matthews E., Guet A., Mayer M., et al. Neonatal hypotonia can be a sodium channelopathy: recognition of a new phenotype. Neurology 2008, 71:1740-1742.
8. Meola G., Sansone V. Treatment in myotonia and periodic paralysis. Rev Neurol (Paris) 2004, 160:S55-S69.
9. Nicole S., Davoine C.S., Topaloglu H., et al. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet 2000, 26:480-483.
10. Plaster N.M., Tawil R., Tristani-Firouzi M., et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 2001, 105:511-519.
11. Rüdel R., Lehmann-Horn F. Paramyotonia, potassium-aggravated myotonias and periodic paralyses. 37th ENMC International Workshop, Naarden, The Netherlands, 8-10 December 1995. Neuromuscul Disord 1997, 7:127-132.
12. Tawil R., Ptacek L.J., Pavlakis S.G., et al. Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann Neurol 1994, 35:326-330.
13. Venance S.L., Cannon S.C., Fialho D., et al. The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain 2006, 129:8-17.
14. Vicart S., Sternberg D., Fournier E., et al. New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis. Neurology 2004, 63:2120-2127.